Related Experiment Video
Updated: Feb 7, 2026

08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.2K
The Anxious Bipolar Phenotype: Clinical Complexity and Treatment Resistance
Balwinder Singh1, Ada Man-Choi Ho1, Brandon Coombes1
1Mayo Clinic.
Research Square
|February 6, 2026
Summary
Individuals with bipolar disorder (BD) and comorbid anxiety disorders (ANX) are younger, more likely female, and experience more severe symptoms. They also show poorer treatment response to mood stabilizers and are more often prescribed antidepressants and benzodiazepines.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Anxiety disorders (ANX) affect a significant portion of individuals with bipolar disorder (BD), ranging from 30-60%.
- Limited research has systematically explored the clinical characteristics and treatment patterns of this comorbid population.
- Understanding these differences is crucial for effective patient management.
Purpose of the Study:
- To investigate demographic, clinical, and pharmacotherapeutic differences between individuals with BD with and without comorbid ANX.
- To identify distinct clinical profiles and treatment responses in the BD + ANX subgroup.
- To inform the development of anxiety-informed treatment algorithms for BD.
Main Methods:
- Cross-sectional analysis of 2,225 adults with BD from the Mayo Clinic Bipolar Disorder Biobank.
- Assessment of comorbid ANX, demographics, clinical features, medication use, and treatment response (Alda-A scale).
- Comparison of clinical characteristics and pharmacotherapy between BD + ANX and BD-only groups.
Main Results:
- 61% of individuals with BD had comorbid ANX.
- BD + ANX individuals were younger, more likely female, and had higher rates of rapid cycling, suicide attempts, substance use disorders, and somatic comorbidities.
- BD + ANX patients received less lithium and valproic acid but more antidepressants, benzodiazepines, and gabapentinoids; 17.3% received antidepressants without mood stabilizer coverage.
- Treatment response scores (Alda-A) were significantly lower for lithium, mood-stabilizing anticonvulsants, and second-generation antipsychotics in the BD + ANX group.
Conclusions:
- Individuals with BD + ANX represent a more severely affected subgroup with distinct clinical and demographic profiles.
- Prescribing patterns in BD + ANX favor antidepressants over mood stabilizers, with an attenuated response to mood stabilizers.
- Anxiety comorbidity in BD is a significant negative prognostic factor, necessitating anxiety-informed treatment strategies.
Related Concept Videos
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Bipolar Disorder
817
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
817
Bipolar Junction Transistor
1.5K
Bipolar Junction Transistors (BJTs) are essential elements in electronic circuits, playing a crucial role in the functionality of amplifiers, memories, and microprocessors. These transistors can be designed as NPN or PNP based on their doping patterns. They consist of three layers: the emitter, base, and collector. The configuration of these layers and their respective doping levels—with N-type or P-type impurities—define the transistor's type and its operational...
1.5K
Resistivity
4.6K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance
6.0K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
Protein Complex Assembly
16.8K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.8K

